[Anti-arrhythmia activity of befol, sufan, mexidol, and T3-146 in combination with other anti-arrhythmia agents].
Galenko-Iaroshevskiĭ
P A
PA
Uvarov
A V
AV
Sheĭkh-Zade
Iu R
IuR
Cherednik
I L
IL
Popov
P B
PB
Turovaia
A Iu
AIu
Khankoeva
A I
AI
Sirotenko
D V
DV
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000517:prevention & control*; D001157:Arterial Occlusive Diseases / Q000150:complications; D001549:Benzamides / Q000494:pharmacology; D002415:Cats; D003327:Coronary Disease / Q000150:complications; D004357:Drug Synergism; D009025:Morpholines / Q000494:pharmacology; D015428:Myocardial Reperfusion Injury / Q000150:complications; D010847:Picolines / Q000494:pharmacology; D010889:Piracetam / Q000494:pharmacology; D013386:Succinates / Q000494:pharmacology; D014364:Tryptophan / Q000031:analogs & derivatives / Q000494:pharmacology
D000889:Anti-Arrhythmia Agents; D001549:Benzamides; D009025:Morpholines; D010847:Picolines; D013386:Succinates; C107888:sufan; C070020:emoxypine succinate; C059049:befol; D014364:Tryptophan; D010889:Piracetam
Protivoaritmicheskaia aktivnost' befola, sufana, meksidola i T3-146 v sochetanii s nekotorymi antiaritmikami.